{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:05:48Z","timestamp":1788998748601,"version":"build-2803163510"},"reference-count":30,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2002,10,17]],"date-time":"2002-10-17T00:00:00Z","timestamp":1034812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Pineal Research"],"published-print":{"date-parts":[[2002,11]]},"abstract":"<jats:p><jats:bold>Abstract:<\/jats:bold> Myocardial ischemia\u2013reperfusion (I\/R) represents a clinically relevant problem associated with thrombolysis, angioplasty and coronary bypass surgery. I\/R injury is believed to be a consequence of free radical generation in the heart especially during the period of reperfusion. The pineal secretory product, melatonin, is known to be a potent free radical scavenger and pharmacological concentrations have been shown to reduce the I\/R\u2010induced cardiac damage in isolated rat hearts. However, the physiological role of melatonin in the prevention of this damage is unknown. Rats were pinealectomized or sham\u2010operated (control) 2\u00a0months before the I\/R studies. To produce cardiac damage, the left main coronary artery was occluded for 30\u00a0min, followed by 120\u00a0min reperfusion, in anesthetized rats. Infarct size, expressed as the percentage of the risk zone, was found significantly higher in pinealectomized rats (49\u00b13.4%) than in the control group (34\u00b13.6%). Melatonin administration (4\u00a0mg\/kg, either before ischemia or reperfusion) to pinealectomized rats significantly reduced the infarct size values and returned them to the control values. On the other hand, melatonin administration (4\u00a0mg\/kg) to sham\u2010operated rats failed to attenuate significantly the I\/R\u2010induced infarct size. These results suggest that physiological melatonin concentrations are important in reducing the I\/R\u2010induced myocyte damage, while pharmacological concentrations of melatonin did not add to the beneficial effect. As melatonin levels have been reported to decrease with age, melatonin replacement therapy may attenuate I\/R\u2010induced myocardial injury, especially in older patients.<\/jats:p>","DOI":"10.1034\/j.1600-079x.2002.02924.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T08:32:41Z","timestamp":1047457961000},"page":"234-238","source":"Crossref","is-referenced-by-count":79,"title":["Myocardial ischemia\u2013reperfusion in rats: reduction of infarct size by either supplemental physiological or pharmacological doses of melatonin"],"prefix":"10.1034","volume":"33","author":[{"given":"Engin","family":"Sahna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"Acet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kaya Ozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercument","family":"Olmez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,10,17]]},"reference":[{"key":"e_1_2_11_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0008-6363(00)00078-X"},{"key":"e_1_2_11_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-5273(96)02854-9"},{"key":"e_1_2_11_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb09920.x"},{"key":"e_1_2_11_5_2","doi-asserted-by":"publisher","DOI":"10.1385\/CBB:34:2:237"},{"key":"e_1_2_11_6_2","first-page":"171","article-title":"Melatonin: mechanisms and actions as an antioxidant","volume":"24","author":"Reiter RJ","year":"2000","journal-title":"Curr Top Biophys"},{"key":"e_1_2_11_7_2","first-page":"45","article-title":"Beneficial neurobiological effects of melatonin under conditions of increased oxidative stress","volume":"2","author":"Reiter RJ","year":"2002","journal-title":"Curr Med Chem"},{"key":"e_1_2_11_8_2","doi-asserted-by":"publisher","DOI":"10.1081\/CNV-120001154"},{"key":"e_1_2_11_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(94)03437-X"},{"key":"e_1_2_11_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1998.tb00558.x"},{"key":"e_1_2_11_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(00)00607-X"},{"key":"e_1_2_11_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0024-3205(99)00620-7"},{"key":"e_1_2_11_13_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-079x.2002.1o853.x"},{"key":"e_1_2_11_14_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02124114"},{"key":"e_1_2_11_15_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.27.1.7"},{"key":"e_1_2_11_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/27.1.116"},{"key":"e_1_2_11_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(91)90286-5"},{"key":"e_1_2_11_18_2","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.1998.78.3.687"},{"key":"e_1_2_11_19_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF03350359"},{"key":"e_1_2_11_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(00)00467-8"},{"key":"e_1_2_11_21_2","first-page":"135","article-title":"Antioxidant therapy: a new pharmacological approach in shock, inflammation, and ischemia\/reperfusion injury","volume":"53","author":"Cuzzocrea S","year":"2001","journal-title":"Pharmacol Rev"},{"key":"e_1_2_11_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-2999(01)01175-X"},{"key":"e_1_2_11_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1993.tb00500.x"},{"key":"e_1_2_11_24_2","first-page":"747","article-title":"Melatonin and coronary heart disease","volume":"109","author":"Marktl W","year":"1997","journal-title":"Wien Klin Wochenschr"},{"key":"e_1_2_11_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0895-7061(97)00401-9"},{"key":"e_1_2_11_26_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-079X.1994.tb00102.x"},{"key":"e_1_2_11_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(97)01178-2"},{"key":"e_1_2_11_28_2","doi-asserted-by":"publisher","DOI":"10.1159\/000014636"},{"key":"e_1_2_11_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004647-199905000-00005"},{"key":"e_1_2_11_30_2","doi-asserted-by":"publisher","DOI":"10.1177\/107424849800300208"},{"key":"e_1_2_11_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/bies.950140307"}],"container-title":["Journal of Pineal Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1034%2Fj.1600-079X.2002.02924.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1034\/j.1600-079X.2002.02924.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T01:36:30Z","timestamp":1697506590000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1034\/j.1600-079X.2002.02924.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,10,17]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1034\/j.1600-079X.2002.02924.x"],"URL":"https:\/\/doi.org\/10.1034\/j.1600-079x.2002.02924.x","archive":["Portico"],"relation":{},"ISSN":["0742-3098","1600-079X"],"issn-type":[{"value":"0742-3098","type":"print"},{"value":"1600-079X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,10,17]]}}}